Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: A meta-analysis of randomized controlled trials

Clinical Infectious Diseases

Volumn 59, Issue 12, 2014, Pages 1741-1749

  Zacharioudakis, Ioannis M ^a,b   Zervou, Fainareti N ^a,b   Arvanitis, Marios ^a,b   Ziakas, Panayiotis D ^a,b   Mermel, Leonard A ^a,b   Mylonakis, Eleftherios ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

central venous catheters; CLABSI; CRBSI; infection; lock

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL LOCK SOLUTION; CEFAZOLIN; CITRATE SODIUM; CITRIC ACID; EDETIC ACID; FUSIDIC ACID; GENTAMICIN; HEPARIN; LINEZOLID; METHYLENE BLUE; PROPYL PARABEN; TAUROLIDINE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; CANCER PATIENT; CATHETER INFECTION; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CRITICALLY ILL PATIENT; DRUG EFFICACY; EMBASE; HEMODIALYSIS; HUMAN; INFECTION CONTROL; INFECTION RATE; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TOTAL PARENTERAL NUTRITION; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION;

ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84924982279     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu671     Document Type: Article

References (36)

1. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173:2039-46.
2. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32:101-14.
3. Schiffer CA, Mangu PB,Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013; 31:1357-70.
4. James MT, Conley J, Tonelli M, et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008; 148:596-605.
5. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008; 47:83-93.
6. Niyyar VD, Lok CE. Pros and cons of catheter lock solutions. Curr Opin Nephrol Hypertens 2013; 22:669-74.
7. Mokrzycki MH. Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters. Nat Clin Pract Nephrol 2008; 4:478-9.
8. Betjes MG. Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol 2011; 7:257-65.
9. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-93.
10. Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:753-71.
11. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8:336-41.
13. National Healthcare Safety Network. Central line-associated bloodstream infection (CLABSI) event. Available at: http://www.cdc.gov/nhsn/pdfs/ pscmanual/4psc-clabscurrent.pdf. Accessed 15 January 2014.
14. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928.
15. Berenholtz SM, Lubomski LH, Weeks K, et al. Eliminating central lineassociated bloodstream infections: a national patient safety imperative. Infect Control Hosp Epidemiol 2014; 35:56-62.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21:1539-58.
17. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006; 25:3443-57.
18. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56:455-63.
19. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326:219.
20. Sofroniadou S, Revela I, Smirloglou D, et al. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheterrelated blood stream infections in hemodialysis patients: a prospective randomized study. Semin Dial 2012; 25:344-50.
21. Centers for Disease Control and Prevention. Vital signs: central lineassociated blood stream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243-8.
22. Mermel LA. What is the predominant source of intravascular catheter infections? Clin Infect Dis 2011; 52:211-2.
23. Maiefski M, Rupp ME, Hermsen ED. Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol 2009; 30:1096-108.
24. Wales PW, Kosar C, Carricato M, de Silva N, Lang K, Avitzur Y. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg 2011; 46:951-6.
25. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-5.
26. Soriano A, Bregada E, Marques JM, et al. Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin. Eur J Clin Microbiol Infect Dis 2007; 26:659-61.
27. Chauhan A, Lebeaux D, Decante B, et al. A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 2012; 7:e37281.
28. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010; 5:1799-804.
29. Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of Heparin versus Ethanol Lock Therapy for the Prevention of Catheter Associated Infection in Haemodialysis patients-the HEALTHY-CATH trial. BMC Nephrol 2012; 13:146.
30. Liu Y, Zhang AQ, Cao L, Xia HT, Ma JJ. Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013; 8:e79417.
31. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheterrelated bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010; 5:e10840.
32. Zhang P, Yuan J, Tan H, Lv R, Chen J. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 2009; 27:206-11.
33. US Food and Drug Administration.Warning on tricitrasol dialysis catheter anticoagulant. FDA Talk Paper 2000; 16. Available at: http://www. hdcn.com/00/004fdci.htm. Accessed 26 December 2013.
34. Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother 2014; 69:2611-9.
35. Polaschegg HD. Loss of catheter locking solution caused by fluid density. ASAIO J 2005; 51:230-5.
36. Mermel LA. What is the evidence for intraluminal colonization of hemodialysis catheters? Kidney Int 2014; 86:28-33.